If you don't see
a heading to this page, please, use
this link
J.
Inmaculada
Pérez Dorado
Associate Scientist
See below my further links
Telf.: +34
91 561 94 00 (ext. 442055)
+34 91 389 16 96 (direct call)
Fax: +34 91
564 24 31
Personal data
- Associate Scientist, 2023- (Spanish
National Research Council, CSIC)
- Research Fellow,
2020-2023 (Spanish
National Research Council, CSIC)
- Senior Scientist in
Structural Biology, 2018-2020 (Evotec
UK Ltd,
Abingdon, UK)
-
Research Associate, 2013-2017 (Imperial
College London, London, UK)
-
Postdoctoral Researcher, 2012-2013 (Lab.
of Molecular Biology-Medical Research Council, Cambridge, UK)
-
Long-Term Postdoctoral FEBS Fellow, 2009-2012 (Lab.
of Molecular Biology-Medical Research Council, Cambridge, UK)
-
Postdoctoral Researcher, 2009 (Lab.
of Molecular
Biology-Medical Research Council, Cambridge, UK)
- Ph.D. in
Biochemistry, 2008 (Univ.
Complutense de Madrid,
Madrid, Spain)
- Predoctoral Fellow
I3P-CSIC,
2005-2008 (Spanish
National Research Council, CSIC)
- Bruker-Nonius Research
Fellow, 2002-2004 (Spanish
National Research Council, CSIC)
- Ms.
Sci. in Biochemistry 2001 (Univ.
Complutense de Madrid,
Madrid, Spain)
Professional experience
- Molecular Biology and purification of
recombinant proteins
-
Structural biology techniques with strongest background in protein
crystallography
-
Fragment screening and drug discovery using X-ray crystallography
Research interest
My career focuses in the
functional/structural characterization of proteins involved in
host-pathogen interactions and membrane trafficking processes linked to
human disease as main topic, giving also important attention to other
fundamental events such as redox processes. At present my main interest
centres in the structural and functional characterization of virulence
factors from Mycobacterium
tuberculosis, the causative agent of human tuberculosis.
My goal is understanding the molecular basis governing host-pathogen
interactions not fully understood so far in this infectious agent,
information that may lead to find new drug targets and developing new
strategies to fight tuberculosis.
Further links